Brain Clock Reset Drug Extends Lifespan and Reverses Aging Markers in Mice
Scientists discovered that targeting circadian rhythms in a specific brain region can extend lifespan and reverse biological aging.
Summary
Researchers found that restoring circadian rhythms in the brain's paraventricular nucleus can extend lifespan and reverse aging markers in male mice. Using a compound called 3'-deoxyadenosine (3dA) administered at optimal times, scientists strengthened the brain's internal clock, which improved hormone balance and reduced biological age as measured by DNA methylation. The treatment worked by targeting a protein called RUVBL2 that helps regulate circadian gene expression. This discovery suggests that circadian disruption accelerates aging, while restoring robust daily rhythms could be a powerful anti-aging strategy.
Detailed Summary
This groundbreaking study reveals that targeting the brain's master clock could be key to slowing aging and extending healthy lifespan. As we age, our circadian rhythms weaken, contributing to physiological decline and shorter lifespans.
Researchers administered 3'-deoxyadenosine (3dA) to aging male mice at specific times to strengthen circadian rhythms in the paraventricular nucleus (PVN), a brain region that coordinates daily biological cycles. They measured aging biomarkers, hormone levels, gene expression, and lifespan outcomes.
The results were remarkable: mice receiving timed 3dA treatment lived longer and showed reversed biological aging markers. Their DNA methylation patterns indicated younger biological age, hormone rhythms were restored, and cellular clocks became more synchronized. The researchers identified RUVBL2 protein as the key target - when this protein was knocked out, the benefits disappeared.
These findings suggest that circadian dysfunction drives aging, while restoring robust daily rhythms can reverse this process. The PVN acts as a central hub where circadian health influences whole-body aging. This opens exciting possibilities for circadian-based anti-aging therapies.
However, this study was conducted only in male mice, so human applications remain uncertain. The optimal timing and dosing for humans would need extensive research. Additionally, long-term safety of circadian-targeting compounds requires investigation before clinical use.
Key Findings
- Timed 3dA administration extended lifespan and reversed biological aging markers in male mice
- Treatment restored hormone rhythms and strengthened brain circadian clock synchronization
- DNA methylation clocks showed reduced biological age following circadian restoration
- RUVBL2 protein was identified as essential target for circadian anti-aging effects
- Paraventricular nucleus emerged as key brain region linking circadian health to aging
Methodology
Researchers used aging male mice treated with 3'-deoxyadenosine at circadian-optimized times, measuring lifespan, biomarkers, and gene expression. Controls included untreated mice and genetic knockouts of RUVBL2 protein to confirm mechanism.
Study Limitations
Study was conducted only in male mice, limiting generalizability to females and humans. Long-term safety and optimal dosing protocols for potential human applications remain unknown and require extensive clinical research.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.